Browse recruiting and upcoming clinical trials for relapsing polychondritis.
Patient-friendly, AI-assisted summaries based on official ClinicalTrials.gov ↗ records. Last updated: Oct 10, 2026
About this listHide
ClinicalTrials.gov is the complete and most up-to-date source. Trials may be missing, and trial information may have changed since our last check. Always verify important information in the official registry.
Who can join AIAdults aged 18–70 with relapsing polychondritis who meet the revised Michet criteria and had an inadequate response to standard treatment.
What is being studied AITests whether upadacitinib reduces disease activity and evaluates safety versus standard therapy.
Who can join AIPeople with vasculitis—Takayasu's arteritis, giant cell arteritis, polyarteritis nodosa, relapsing polychondritis, or ANCA‑associated vasculitis—plus related family members and healthy volunteers.
What is being studied AICollects clinical data, blood and tissue samples, imaging, and genetics to study vasculitis natural history.